July 20, 2017 - By Ellis Scott
Gemphire Therapeutics Incorporated (NASDAQ:GEMP) had an increase of 12.14% in short interest. GEMP’s SI was 227,200 shares in July as released by FINRA. Its up 12.14% from 202,600 shares previously. With 30,500 avg volume, 7 days are for Gemphire Therapeutics Incorporated (NASDAQ:GEMP)’s short sellers to cover GEMP’s short positions. The SI to Gemphire Therapeutics Incorporated’s float is 6.29%. The stock decreased 3.69% or $0.64 on July 19, reaching $16.71. About shares traded. Gemphire Therapeutics Inc (NASDAQ:GEMP) has 0.00% since July 20, 2016 and is . It has underperformed by 16.70% the S&P500.
Analysts expect SM Energy Co (NYSE:SM) to report $-0.31 EPS on August, 3 after the close.They anticipate $0.13 EPS change or 29.55% from last quarter’s $-0.44 EPS. After having $0.18 EPS previously, SM Energy Co’s analysts see -272.22% EPS growth. The stock increased 6.90% or $1.18 during the last trading session, reaching $18.29. About shares traded. SM Energy Co (NYSE:SM) has declined 24.40% since July 20, 2016 and is downtrending. It has underperformed by 41.10% the S&P500.
Since February 27, 2017, it had 14 buys, and 0 insider sales for $2.00 million activity. The insider PERU RAMIRO G bought 1,000 shares worth $25,422. Another trade for 2,000 shares valued at $32,888 was made by Ottoson Javan D on Thursday, June 8. Quintana Julio M bought 20,000 shares worth $491,800. The insider Vogel Herbert S bought 2,000 shares worth $46,190. Copeland David W had bought 10,000 shares worth $252,200. Another trade for 10,000 shares valued at $256,902 was made by SULLIVAN WILLIAM D on Monday, February 27. $491,472 worth of SM Energy Co (NYSE:SM) shares were bought by LEIKER LOREN M.
Investors sentiment increased to 2.06 in Q4 2016. Its up 0.02, from 2.04 in 2016Q3. It is positive, as 27 investors sold SM Energy Co shares while 58 reduced holdings. 58 funds opened positions while 117 raised stakes. 97.77 million shares or 14.16% more from 85.64 million shares in 2016Q3 were reported. Financial Bank Of Montreal Can owns 145,729 shares for 0.01% of their portfolio. Glg Limited Partnership has 103,743 shares. Systematic Fincl Management Ltd Partnership holds 0.63% or 1.14M shares in its portfolio. State Teachers Retirement Sys holds 123,241 shares. South Dakota Invest Council holds 0.04% or 51,400 shares in its portfolio. Virginia Retirement Et Al reported 55,800 shares or 0.03% of all its holdings. Ameritas Ptnrs invested in 0.05% or 28,954 shares. Boothbay Fund Mgmt Limited holds 0.1% of its portfolio in SM Energy Co (NYSE:SM) for 8,848 shares. California Public Employees Retirement Systems has invested 0.02% in SM Energy Co (NYSE:SM). 1492 Mgmt Limited Liability reported 17,259 shares. Palisade Capital Ltd Liability Co Nj reported 383,247 shares. Kennedy Cap accumulated 1.08 million shares. Utah Retirement has 0.02% invested in SM Energy Co (NYSE:SM). Jane Street Grp Llc reported 0% stake. Moreover, Credit Agricole S A has 0% invested in SM Energy Co (NYSE:SM) for 6,275 shares.
Among 21 analysts covering SM Energy (NYSE:SM), 12 have Buy rating, 0 Sell and 9 Hold. Therefore 57% are positive. SM Energy had 54 analyst reports since July 21, 2015 according to SRatingsIntel. Deutsche Bank maintained it with “Hold” rating and $35 target in Tuesday, June 14 report. The firm earned “Equal Weight” rating on Tuesday, January 19 by CapitalOne. JP Morgan initiated SM Energy Co (NYSE:SM) rating on Wednesday, December 9. JP Morgan has “Neutral” rating and $31 target. The rating was upgraded by Guggenheim on Monday, November 2 to “Buy”. Deutsche Bank maintained the shares of SM in report on Wednesday, August 10 with “Hold” rating. The rating was upgraded by KeyBanc Capital Markets to “Overweight” on Wednesday, August 10. The rating was downgraded by Seaport Global to “Neutral” on Wednesday, June 21. The stock has “Buy” rating by Topeka Capital Markets on Tuesday, October 13. As per Tuesday, March 15, the company rating was maintained by JP Morgan. As per Monday, April 18, the company rating was downgraded by KLR Group.
SM Energy Company is an independent energy company. The company has market cap of $2.02 billion. The Firm is engaged in the acquisition, exploration, development and production of crude oil and condensate, natural gas and natural gas liquids in onshore North America. It currently has negative earnings. It operates in the exploration and production segment of the gas and oil industry within the United States.
Gemphire Therapeutics Inc. is a clinical-stage biopharmaceutical company. The company has market cap of $180.99 million. The Firm is engaged in the development and commercialization of therapeutics to treat cardiovascular and metabolic diseases. It currently has negative earnings. It is developing its product candidate, gemcabene , which is a once-daily, oral therapy for patients who are unable to achieve normal levels of low-density lipoprotein cholesterol (LDL-C) or triglycerides with approved therapies, primarily statin therapy.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.